Atorvastatin (20mg) and Aspirin (75mg)
May 15, 2023
Atorvastatin (20mg) and Aspirin (75mg)
ATOVASTRIN AV is a combination of two medications that are used together to treat different health conditions.
Atorvastatin is a medication that belongs to a class of drugs known as statins. It is primarily used to lower high levels of cholesterol in the blood, which is a major risk factor for cardiovascular disease.
Aspirin, on the other hand, is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used as a pain reliever and fever reducer. It works by blocking the production of certain substances in the body that cause inflammation, pain, and fever. In addition to its analgesic and antipyretic effects, aspirin also has antiplatelet properties, meaning it can help to prevent blood clots from forming in the blood vessels.
ATOVASTRIN AV is used in the prevention and treatment of cardiovascular disease.
STERIS PHARMA deals in Generic medicines that promotes healthy competition in the pharmaceutical industry, which can help to drive down prices and improve overall affordability.
For further information
please contact: info@sterispharma.com
Order now:
https://www.sterisonline.com/product/atovastrin-av-20-133252
Recent Post
What Are Metformin HCl PR 850 mg & Glimepiride 3 mg Tablets?
What Is Keratin Biotin Conditioner? Everything You Need to Know
What Are Tablets of Thiamine Nitrate, Pyridoxine Hydrochloride, Folic Acid and Minerals? A Complete Guide
What Is Montelukast + Levocetirizine Syrup? A Complete Guide
How Dapagliflozin, Teneligliptin & Metformin 1000 ER Work Together for Your Heart and Sugar
The Science of BUDESHINE: How Budesonide Aqueous Spray Works for You
Best Anti-Dandruff Shampoo with Luliconazole, Salicylic Acid & Zinc Pyrithione in 2026
Managing Diabetic Neuropathy: Why Pregabalin, Methylcobalamin & Duloxetine is the Best Trio
Powerful Triple Action Cough Syrup: Terbutaline + Ambroxol + Guaiphenesin for Better Breathing
Dapagliflozin 10mg Glimepiride 2mg Metformin 500mg ER Tablets: Best Triple Therapy for Type 2 Diabetes in 2026